Neos Therapeutics, Inc.·4

Dec 7, 6:05 PM ET

McLaughlin Gerald W. 4

4 · Neos Therapeutics, Inc. · Filed Dec 7, 2018

Insider Transaction Report

Form 4
Period: 2018-12-04
McLaughlin Gerald W.
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2018-12-04$2.04/sh+7,403$15,1207,403 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $2.01 to $2.06, inclusive. The reporting person undertakes to provide Neos Therapeutics, Inc., any security holder of Neos Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Documents

1 file
  • 4
    a4.xmlPrimary

    4